PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 10, 2026European Heart Journal - Case Reports0 citationsOpen Access

Giant Left Atrial Myxoma Presenting as Malignant Heart Failure and Rapid Atrial Fibrillation in a Young Adult. A Case Report

View Full Paper
CFCarlos Solórzano FloresAMA Membreño

Key Result

Surgical resection of a giant left atrial myxoma in a 37-year-old man with severe heart failure led to marked symptomatic improvement and recovery of LVEF from 15-20% to 45-50% at 6 weeks.

Key Points

  • This report explores the clinical presentation and treatment of a giant left atrial myxoma causing heart failure and rapid atrial fibrillation.
  • A 37-year-old man presented with symptoms including atrial fibrillation, elevated NT-proBNP, and cardiomegaly.
  • Echocardiography and computed tomography identified a large mass in the left atrium, leading to surgical resection.
  • Histopathology confirmed the diagnosis of atrial myxoma, with follow-up evaluations assessing left ventricular function.
  • The patient exhibited severe left ventricular systolic dysfunction with an LVEF of 15–20% before surgery.
  • Post-surgical follow-up at 6 weeks showed recovery of left ventricular function with an LVEF of 45–50%.
  • The clinical presentation highlighted tachycardia-induced cardiomyopathy rather than obstructive heart failure.

Study Design

Type

Case Report (n=1)

Structured PICO

P
Population
A 37-year-old man presenting with atrial fibrillation with rapid ventricular response, elevated NT-proBNP, cardiomegaly, pleural effusion, and severe left ventricular systolic dysfunction (LVEF 15–20%) due to a giant left atrial myxoma.
I
Intervention
Surgical resection
O
Outcome
Symptomatic improvement and recovery of left ventricular systolic functionsurrogate

Surgical resection of a giant left atrial myxoma can reverse severe left ventricular dysfunction associated with tachycardia-induced cardiomyopathy.

Abstract

Abstract Background Primary cardiac tumors are rare, with cardiac myxomas representing the most common benign subtype in adults. Despite their benign histology, atrial myxomas may lead to significant clinical manifestations, including arrhythmias and heart failure. Giant left atrial myxomas are particularly uncommon, and their clinical presentation may vary depending on size, location, and associated hemodynamic effects. Case Summary A 37-year-old man presented with atrial fibrillation with rapid ventricular response, elevated NT-proBNP, cardiomegaly, and pleural effusion. Transthoracic and transesophageal echocardiography demonstrated a massively dilated left atrium nearly occupied by a large intracavitary mass, accompanied by severe left ventricular systolic dysfunction (LVEF 15–20%). Computed tomography identified a heterogeneous left atrial mass consistent with atrial myxoma. No Doppler evidence of significant mitral inflow obstruction was identified. The patient underwent surgical resection, and histopathology confirmed atrial myxoma. At 6-week follow-up, the patient demonstrated marked symptomatic improvement with recovery of left ventricular systolic function (LVEF 45–50%). Discussion This case illustrates an uncommon presentation of a giant left atrial myxoma associated with atrial fibrillation and severe but reversible left ventricular dysfunction. The clinical course is consistent with tachycardia-induced cardiomyopathy rather than a purely obstructive mechanism. This case highlights the importance of recognizing arrhythmia-mediated ventricular dysfunction in patients with intracardiac masses, as well as the role of multimodality imaging and timely surgical intervention.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Flores et al. (2026) conducted a case report in Giant left atrial myxoma (n=1). Surgical resection was evaluated on Symptomatic improvement and recovery of left ventricular systolic function. Surgical resection of a giant left atrial myxoma in a 37-year-old man with severe heart failure led to marked symptomatic improvement and recovery of LVEF from 15-20% to 45-50% at 6 weeks.

synapsesocial.com/papers/6a0021cdc8f74e3340f9cca0https://doi.org/10.1093/ehjcr/ytag332
Ask AI
Helpful
Bookmark
Share
View Full Paper